CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 111 filers reported holding CLOVIS ONCOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $40,540,000 | +31.6% | 912,651 | +6.8% | 0.01% | +20.0% |
| Q3 2016 | $30,805,000 | +172.8% | 854,514 | +3.8% | 0.01% | +150.0% |
| Q2 2016 | $11,292,000 | -28.7% | 823,036 | -0.2% | 0.00% | -33.3% |
| Q1 2016 | $15,842,000 | -41.3% | 825,085 | +7.1% | 0.00% | -25.0% |
| Q4 2015 | $26,971,000 | -61.2% | 770,609 | +1.9% | 0.00% | -66.7% |
| Q3 2015 | $69,575,000 | +14.6% | 756,580 | +9.5% | 0.01% | +20.0% |
| Q2 2015 | $60,708,000 | +13.6% | 690,801 | -4.0% | 0.01% | +25.0% |
| Q1 2015 | $53,418,000 | +33.3% | 719,622 | +0.5% | 0.01% | +33.3% |
| Q4 2014 | $40,080,000 | +18.4% | 715,720 | -4.1% | 0.01% | 0.0% |
| Q3 2014 | $33,862,000 | +6.9% | 746,516 | -2.4% | 0.01% | +20.0% |
| Q2 2014 | $31,668,000 | -51.6% | 764,733 | -19.0% | 0.01% | -54.5% |
| Q1 2014 | $65,389,000 | +68.6% | 943,970 | +46.7% | 0.01% | +57.1% |
| Q4 2013 | $38,781,000 | +51.1% | 643,462 | +52.5% | 0.01% | +40.0% |
| Q3 2013 | $25,658,000 | +43.9% | 422,004 | +58.6% | 0.01% | +25.0% |
| Q2 2013 | $17,826,000 | – | 266,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |